Aytu Biopharma (AYTU) FCF Margin (2013 - 2026)
Aytu Biopharma (AYTU) posted quarterly FCF Margin of 33.7% for Q1 2026, up 166.0% year-over-year from 12.67% in Q1 2025, and down 239.69% quarter-over-quarter from 24.12% in Q4 2025.
Aytu Biopharma (AYTU) FCF Margin (2013 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported FCF Margin for 14 consecutive years, with 33.7% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin rose 166.0% year-over-year to 33.7%; the TTM figure through Mar 2026 stood at 2.9% (up 1212.0% YoY), while the FY2025 annual figure was 3.26%, down 63.0% from the prior year.
- FCF Margin slipped to 33.7% in Q1 2026 per AYTU's latest filing, from 24.12% in the prior quarter.
- Across five years, FCF Margin topped out at 30.49% in Q2 2023 and bottomed at 37.67% in Q1 2022.
- Historically, FCF Margin has averaged 7.1% across 5 years, with a median of 7.65% in 2024.
- Annual changes were most pronounced in 2022 — FCF Margin slumped 5463 bps — and 2023, when it surged 5634 bps.
- Aytu Biopharma's FCF Margin stood at 9.47% in 2022, then jumped by 92 bps to 0.72% in 2023, then soared by 2582 bps to 17.87% in 2024, then jumped by 35 bps to 24.12% in 2025, then tumbled by 240 bps to 33.7% in 2026.
- Business Quant data shows AYTU's FCF Margin at 33.7% in Q1 2026, 24.12% in Q4 2025, and 4.45% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Aytu Biopharma | 24.49 Mn | -2.22 Mn | 7.60 Mn | -33.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.70% |
| Dec 31, 2025 | 24.12% |
| Sep 30, 2025 | -4.45% |
| Jun 30, 2025 | 18.41% |
| Mar 31, 2025 | -35.36% |
| Dec 31, 2024 | 17.87% |
| Sep 30, 2024 | -8.00% |
| Jun 30, 2024 | -7.65% |
| Mar 31, 2024 | -1.81% |
| Dec 31, 2023 | -0.72% |
| Sep 30, 2023 | -1.18% |
| Jun 30, 2023 | 30.49% |
| Mar 31, 2023 | -12.81% |
| Dec 31, 2022 | -9.47% |
| Sep 30, 2022 | -32.91% |
| Jun 30, 2022 | -25.85% |
| Mar 31, 2022 | -37.67% |
| Dec 31, 2021 | -38.11% |
| Sep 30, 2021 | -17.35% |
| Jun 30, 2021 | 28.78% |